Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 151.6537 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 11 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,203.9406 Underlying: Common Shares · 151.6537 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 999.7294 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,188.0924 Underlying: Common Shares · 999.7294 shares Expires 2025-02-25 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 123.9609 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,514.5921 Underlying: Common Shares · 123.9609 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 41.0408 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,467.6293 Underlying: Common Shares · 41.0408 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,747.4886 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,807.6692 Underlying: Common Shares · 1,747.4886 shares Expires 2025-02-21 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 126.2997 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000063 · wk-form4_1712621306.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,826.1742 Underlying: Common Shares · 126.2997 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 401.3185 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,465.3185 Underlying: Common Shares · 401.3185 shares Expires 2027-03-15 F13 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 101.0481 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 12 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,462.0481 Underlying: Common Shares · 101.0481 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 575.8114 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 11 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,711.9832 Underlying: Common Shares · 575.8114 shares Expires 2026-02-22 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 91.7865 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 10 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,228.1811 Underlying: Common Shares · 91.7865 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 319.9073 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 9 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,619.3768 Underlying: Common Shares · 319.9073 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 56.3503 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 8 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,507.2214 Underlying: Common Shares · 56.3503 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 16.4397 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 7 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,190.1773 Underlying: Common Shares · 16.4397 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 349.4977 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 6 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,561.5338 Underlying: Common Shares · 349.4977 shares Expires 2025-02-21 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 23.7221 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000059 · wk-form4_1712621261.xml · derivative · entry 5 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,160.3641 Underlying: Common Shares · 23.7221 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 149.9209 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 12 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,982.9209 Underlying: Common Shares · 149.9209 shares Expires 2027-03-15 F13 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning Febuary 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 72.6284 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 11 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,680.6284 Underlying: Common Shares · 72.6284 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 169.7605 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,627.3326 Underlying: Common Shares · 169.7605 shares Expires 2026-02-22 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 51.991 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 9 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,929.8739 Underlying: Common Shares · 51.991 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 197.9824 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 8 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,389.0254 Underlying: Common Shares · 197.9824 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 45.4709 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 7 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,060.8022 Underlying: Common Shares · 45.4709 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 14.0191 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 6 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,868.6085 Underlying: Common Shares · 14.0191 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 218.3044 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 5 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,097.735 Underlying: Common Shares · 218.3044 shares Expires 2025-02-21 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 22.9743 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000061 · wk-form4_1712621283.xml · derivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,062.2456 Underlying: Common Shares · 22.9743 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 351.1537 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 14 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,782.1537 Underlying: Common Shares · 351.1537 shares Expires 2027-03-15 F15 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 105.427 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 13 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,045.427 Underlying: Common Shares · 105.427 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 287.9057 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 12 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,355.9916 Underlying: Common Shares · 287.9057 shares Expires 2026-02-22 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 52.0883 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 11 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939.42 Underlying: Common Shares · 52.0883 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 319.9073 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 10 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,619.3768 Underlying: Common Shares · 319.9073 shares Expires 2025-02-25 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 35.0609 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 9 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,670.9681 Underlying: Common Shares · 35.0609 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 21.5175 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 8 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866.6541 Underlying: Common Shares · 21.5175 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 169.0493 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 7 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,521.4463 Underlying: Common Shares · 169.0493 shares Expires 2025-02-21 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 174.7488 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 6 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,280.7669 Underlying: Common Shares · 174.7488 shares Expires 2025-02-21 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:07 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 62.5863 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000057 · wk-form4_1712621237.xml · derivative · entry 5 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,338.0067 Underlying: Common Shares · 62.5863 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 17:32 UTC |
KLEIN JEFFREY WPresident, Popeyes-US & Canada
|
GrantPerformance Share Units · Derivative | 12,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000033 · wk-form4_1710970355.xml · derivative · entry 7 KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,141 Underlying: Common Shares · 12,656 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:32 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 12,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000032 · wk-form4_1710970341.xml · derivative · entry 16 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,575 Underlying: Common Shares · 12,656 shares Expires 2027-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:33 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 4,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000034 · wk-form4_1710970375.xml · derivative · entry 14 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,368 Underlying: Common Shares · 4,429 shares Expires 2027-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:44 UTC |
Granat JillSee Remarks
|
Exercise / conversionOption (Right to Buy) · Derivative | 66,667 | $0.00 Strike: $42.26 | $0.00 |
DisclosureSEC source: 0000950170-24-020547 · ownership.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 66,667 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:44 UTC |
Granat JillSee Remarks
|
Exercise / conversionOption (Right to Buy) · Derivative | 13,665 | $0.00 Strike: $42.26 | $0.00 |
DisclosureSEC source: 0000950170-24-020547 · ownership.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 13,665 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:44 UTC |
Granat JillSee Remarks
|
SaleCommon Shares | 80,332 | $76.20 | $6,121,298.40 |
DisclosureSEC source: 0000950170-24-020547 · ownership.xml · nonDerivative · entry 6 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,759.3554 F5 · price: Represents the weighted average price of the shares sold. The reported shares were sold at prices ranging from $75.65 to $76.51 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:44 UTC |
Granat JillSee Remarks
|
Exercise / conversionCommon Shares | 66,667 | $42.26 | $2,817,347.42 |
DisclosureSEC source: 0000950170-24-020547 · ownership.xml · nonDerivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491,091.3554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:44 UTC |
Granat JillSee Remarks
|
Exercise / conversionCommon Shares | 13,665 | $42.26 | $577,482.90 |
DisclosureSEC source: 0000950170-24-020547 · ownership.xml · nonDerivative · entry 4 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,424.3554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 02:41 UTC |
Fulton DuncanChief Corporate Officer
|
SaleCommon Shares | 32,500 | $76.44 | $2,484,300.00 |
DisclosureSEC source: 0000950170-24-020542 · ownership.xml · nonDerivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,385.9571 F6 · price: Represents the weighted average price of the share sold. The prices of the shares sold pursuant to the transaction ranged from $76.37 to $76.52 per share. The reported shares were sold in Canadian dollars and was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on the sale date. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 02:42 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 26,532 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020544 · ownership.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,532 Underlying: Common Shares · 26,532 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 02:42 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 9,935 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020544 · ownership.xml · derivative · entry 6 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,935 Underlying: Common Shares · 9,935 shares Expires not disclosed F7 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F8 · shares: The Issuers grant the 2024 restricted share units ("2024 RSUs") to the Reporting Person pursuant to the Issuer's 2023 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2023 net bonus to purchase Investment Shares and received a matching grant of 2024 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $75.38 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2024 RSUs that have not yet vested. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 02:42 UTC |
Housman JeffreySee Remarks
|
GrantCommon Shares | 2,649 | $75.38 | $199,681.62 |
DisclosureSEC source: 0000950170-24-020544 · ownership.xml · nonDerivative · entry 4 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,228.4845 F4 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2023 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2023 net bonus to purchase common shares at a purchase price of $75.38 per share ("Investment Shares"). F5 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the Trading day immediately preceding the grant date, in this case February 22, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 02:42 UTC |
Housman JeffreySee Remarks
|
SaleCommon Shares | 30,000 | $75.51 | $2,265,300.00 |
DisclosureSEC source: 0000950170-24-020544 · ownership.xml · nonDerivative · entry 3 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,579.4845 F3 · price: Represents the weighted average price of the share sold. The prices of the shares sold pursuant to the transaction ranged from $75.28 to $75.73 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:39 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 59,697 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020540 · ownership.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,697 Underlying: Common Shares · 59,697 shares Expires 2027-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:39 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 13,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020540 · ownership.xml · derivative · entry 5 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,925 Underlying: Common Shares · 13,925 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F7 · shares: The Issuer granted the 2024 restricted share units ("2024 RSUs") to the Reporting Person pursuant to the Issuer's 2023 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2023 net bonus to purchase Investment Shares and received a matching grant of 2024 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $75.38 per share. The RSU Multiplier was 2.25 for executive vice president or above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2024 RSUs that have not yet vested. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:39 UTC |
Shear David ChanPresident, International
|
GrantCommon Shares | 3,713 | $75.38 | $279,885.94 |
DisclosureSEC source: 0000950170-24-020540 · ownership.xml · nonDerivative · entry 3 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,602.5126 F3 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2023 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2023 net bonus to purchase common shares at a purchase price of $75.38 per share ("Investment Shares"). F4 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 22, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.